Related Experiment Video
Updated: Jun 13, 2025

03:14
Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
Published on: December 6, 2024
519
Closing the gap between open source and commercial large language models for medical evidence summarization
Gongbo Zhang1, Qiao Jin2, Yiliang Zhou3
1Department of Biomedical Informatics, Columbia University, New York, NY, USA.
NPJ Digital Medicine
|September 9, 2024
Summary
Fine-tuning open-source large language models (LLMs) significantly improves their medical evidence summarization capabilities. Even smaller fine-tuned models can outperform larger proprietary ones, enhancing transparency and customization in medical AI.
Area of Science:
- Artificial Intelligence
- Medical Informatics
- Natural Language Processing
Background:
- Large language models (LLMs) show potential for summarizing medical evidence.
- Proprietary LLMs present risks like lack of transparency and vendor dependency.
- Open-source LLMs offer transparency but generally underperform proprietary models.
Purpose of the Study:
- To evaluate the impact of fine-tuning on the performance of open-source LLMs for medical evidence summarization.
- To compare the performance of fine-tuned open-source LLMs against proprietary models.
Main Methods:
- Fine-tuned three open-source LLMs (PRIMERA, LongT5, Llama-2) using the MedReview dataset (8161 systematic review-summary pairs).
- Evaluated performance through human assessment and GPT-4 simulated evaluation.
- Compared fine-tuned models against zero-shot proprietary models (e.g., GPT-3.5).
Main Results:
- Fine-tuning enhanced the performance of all tested open-source LLMs.
- Fine-tuned LongT5 achieved performance comparable to GPT-3.5 in zero-shot settings.
- Smaller fine-tuned models sometimes surpassed larger zero-shot models in summarization quality.
Conclusions:
- Fine-tuning is an effective strategy to improve open-source LLM performance for medical evidence summarization.
- Open-source LLMs, when fine-tuned, can offer a competitive and transparent alternative to proprietary models.
- This approach enhances the utility of LLMs in medical research and clinical practice.
More Related Videos
Related Concept Videos
Improving Translational Accuracy
2.5K
2.5K
Genomics
36.2K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
36.2K
Bioequivalence: Overview
944
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
944
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Pharmacokinetic Models: Overview
618
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
618
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K

